News

The United States Food and Drug Administration (FDA) has granted Orphan Drug Designation in the United States for Biotie's BTT1023 drug candidate for the treatment of primary sclerosing cholangitis (PSC). PSC is a chronic and progressive fibrotic liver disease...

Mylan N.V. announced that the U.S. Patent and Trademark Office (PTO) has ruled in favor of Mylan in its inter partes review (IPR) proceeding and found all claims of two related Copaxone® 40 mg/mL patents to be unpatentable. The...

Bristol-Myers Squibb Company and Pfizer Inc announced that 19 abstracts (late-breaking, rapid-fire, oral and poster presentations) will be presented at ESC Congress 2016, to be held August 27–31 in Rome, Italy. These new data from post-hoc analyses from ARISTOTLE...

Eisai Co., Ltd and MAMORIO, Inc announced that they have entered into an agreement to collaborate on the development of the Me-MAMORIO1 tracking tool to support people with dementia going out. The two companies will conduct a demonstration experiment...

Valeant Pharmaceuticals International, Inc announced that it has entered into a licensing agreement with Norgine B.V. ("Norgine"); under which Valeant has obtained the rights to develop and commercialize NER1006 Powder for Oral Solution in the U.S. and Canada. NER1006...

Optima has expanded its machine range to include new entry-level solutions. These solutions currently include the flexible and completely attuned filling and closing machines OPTIMA FM1 and CM1. These new systems can also be used as stand-alone units. Turnkey...

Aphena Pharma Solutions is pleased to announce the relocation and major expansion of our chocolated pharmaceutical manufacturing operations.   Offerings include brand-equivalent formulations of senna OTC laxatives (compare to Ex-Lax ®) marketed as private-label products. All production has been...